Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This phase II clinical trial studies how well omega-3 fatty acid works in treating patients
with stage I-III breast cancer. Studying samples of tissue and blood in the laboratory from
breast cancer patients receiving omega-3 fatty acid may help doctors learn more about the
effects of omega-3 fatty acid on tumor cells.